Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.36 is in line with its 1-year average of 1.24, near the high end of its 1-year range (0.89–1.51).
As of the fiscal period ended Friday, July 31, 2026. 2.21% above its 12-month average of 1.33.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2026 (2026-07-31): 1.36.
QUICK RATIO (ACID-TEST)
1.36
QUICK RATIO (ACID-TEST) AVG TTM
1.33
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.21%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 792 covered companies
CURRENT VS SECTOR MEDIAN
-58.63%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.52B
Quick Ratio (Acid-Test)
1.36
TTM Avg
1.33
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.66B
Quick Ratio (Acid-Test)
22.20
TTM Avg
29.94
3Y Avg
20.76
5Y Avg
18.56
Market Cap
$5.30B
Quick Ratio (Acid-Test)
3.28
TTM Avg
2.29
3Y Avg
2.05
5Y Avg
2.40
Market Cap
$5.76B
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.21
3Y Avg
3.75
5Y Avg
4.96
Market Cap
$5.27B
Quick Ratio (Acid-Test)
2.53
TTM Avg
2.36
3Y Avg
1.93
5Y Avg
1.92
Market Cap
$5.19B
Quick Ratio (Acid-Test)
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$5.18B
Quick Ratio (Acid-Test)
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.52B | 1.36 | 1.33 | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.48 | 1.94 | 1.50 | 1.26 |
| CG Oncology Inc. (CGON)vs › | $5.66B | 22.20 | 29.94 | 20.76 | 18.56 |
| Doximity, Inc. (DOCS)vs › | $5.32B | 6.08 | 6.53 | 6.56 | 6.07 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.30B | 3.28 | 2.29 | 2.05 | 2.40 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.76B | 3.49 | 3.21 | 3.75 | 4.96 |
| Sotera Health Company (SHC)vs › | $5.27B | 2.53 | 2.36 | 1.93 | 1.92 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.19B | 17.85 | 17.70 | 17.06 | 17.77 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.18B | 13.57 | 9.78 | 9.13 | 11.38 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.92B | 3.82 | 3.07 | 3.52 | 5.23 |
Quick Ratio
1.36
Excludes inventory
Current Ratio
1.81
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 1.36 |
| 2026-04-24 | 1.43 |
| 2026-01-31 | 1.01 |
| 2025-10-31 | 1.51 |
| 2025-04-30 | 0.89 |
